A Live Surgery That Redefined the Future of Bipolar Enucleation
What if a single live surgery could shift the standards of bipolar enucleation for years to come. This question became a reality during the Urovivo Congress in Buenos Aires, where a remarkable Prostate Enucleation procedure using PlasmaLEP technology captured the attention of surgeons, industry leaders, and scientific experts from around the world.
The session highlighted the growing global interest in PlasmaLEP as a reliable and efficient solution for prostate enucleation. The live surgery demonstrated precision, stability, and a level of coagulation that ensured a clean surgical field with controlled bleeding even under challenging anatomical conditions. The clarity of the operative view and the depth of coagulation provided by the bipolar system reinforced its value as a powerful alternative to conventional techniques.
The session was moderated by Mohammed Omar and Prof. Dr. Thomas RW Herrmann, both recognized for their expertise in bipolar enucleation. Their guidance and scientific commentary allowed attendees to fully understand the technical steps and clinical impact of the procedure.
The surgery itself was performed by Dr. Germán Ramírez Wosnuk, joined by Dr. Federico Fossati. Together they demonstrated how PlasmaLEP enables a smooth and controlled enucleation flow. Their performance offered a masterclass in haemostasis, stability, and surgical efficiency.
Representing Lamidey Noury at the congress were
Geoffrey Crepatte, VP Export Sales and Marketing
A. Christian O., Latin America Sales Manager
Their presence reinforced the company’s commitment to supporting clinicians throughout Latin America and worldwide.
A sincere appreciation is extended to our local partners Sijemedic Srl and Endogical for their collaboration and dedication to advancing urological innovation in the region. Gratitude is also owed to Prof. Norberto Bernardo, Chairman of Urology, whose leadership ensured a scientific event of exceptional quality.
The success of the live surgery and the enthusiastic response from participants reaffirm that PlasmaLEP is contributing to a new era in prostate enucleation. Surgeons are increasingly choosing PlasmaLEP for its reliability, clean operative environment, and outstanding energy performance.
We look forward to returning to Buenos Aires for WCET 2026 and continuing to support the evolution of urological surgical technologies.
Teams interested in learning more about PlasmaLEP or requesting a live demonstration can contact us at any time.
PlasmaLEP continues to advance bipolar enucleation and raise the standards of modern urological surgery.
#PlasmaLEP #Enucleation #Urology #Urovivo2025 #LamideyNoury #BipolarSurgery #MedicalTech
